Clinical characteristics and drug resistance analysis in ICU patients with hospital-acquired infections of Burkholderia cepacia
10.3969/j.issn.1673-4130.2014.20.021
- VernacularTitle:ICU 患者医院获得性感染洋葱伯克霍尔德菌的临床特征及耐药性分析
- Author:
Mi LI
;
Xuefeng LIAO
- Publication Type:Journal Article
- Keywords:
Burkholderia cepacia;
intensive care unit;
hospital-acquired infections;
drug-resistance
- From:
International Journal of Laboratory Medicine
2014;(20):2769-2770,2772
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics and resistance to commonly used antibacterial drugs in the intensive care unit(ICU)patients with hospital-acquired Burkholderia cepacia infection in order to provide the basis for clinical rational treatment.Methods The drug resistance situation in 32 strains of Burkholderia cepacia isolated from the bacterial culture speci-mens submitted by ICU of our hospital from January 2011 to December 2012 was performed the retrospective analysis.Results In the detection sites,the infection was mainly distributed in the lower respiratory tract (62.5%),followed by deep venous catheter (12.5%);the drug susceptibility test revealed that 32 strains of Burkholderia cepacia showed the natural resistance to multiple antibacterial drugs,but which were still sensitive to minocycline,chloromycetin,meropenem,ceftazidime,cefoperazone/sulbactam, these drugs could be used as the first choice of drugs for treating Burkholderia cepacia infection.Conclusion The drug resistance phenomenon of Burkholderia cepacia is very serious in the ICU patients.Clinic should pay great concern to the infections caused by multi-drug resistant Burkholderia cepacia ,the microbiological testing should be conducted as early as possible,and the antibacterial drugs should be rationally selected according to the drug susceptibility testing results.
